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Ischemic colitis is a condition that usually occurs in the
elderly, as a form of vascular disease. However, ischemic
colitis also occurs, though rarely, in healthy young adults.
Moreover, food supplements containing Ephedra sinica or ma
huang have been linked to adverse central nervous and cardio-
vascular events. A 40-year-old man was admitted to our
emergency department after 2 episodes of abdominal pain and
bloody diarrhea that lasted 24 hours. His medical history was
unremarkable for risk factors of bowel ischemia, except for
well-controlled hypertension. However, a weight-loss supple-
ment, Ephedra sinica, had been prescribed for daily use during
the previous month. Both abdominal/pelvic computed tomo-
graphy and colonoscopy revealed findings compatible with
ischemic colitis. His conditions spontaneously improved
without any serious complications, and he was advised to dis-
continue the use of herbal medications containing ephedrine.
In this paper, we describe a case of ischemic colitis that was
potentially linked to the use of ma huang with a review of
the relevant literature.
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INTRODUCTION
Ischemic colitis results from the same conditions
that cause hypoperfusion or embolic/thrombotic
occlusion of the vascular supply of the colon.
1
Many factors may be involved in the hypoper-
fusive state that results in ischemic colitis. Non-
occlusive ischemia is now a well-recognized
condition, though its pathophysiology is still not
completely understood.
2 Vasoconstrictive medica-
tions may be implicated in some cases of non-
occlusive ischemia. These medications include
digitalis, diuretics, estrogen, cocaine, pseudoephe-
drine, methamphetamine, vasopressin, alosetron,
and non-steroidal anti-inflammatory drugs.
1,2
Ephedra sinica or ma huang is an evergreen
shrub native to Central Asia, and its primary com-
ponent is ephedrine.
3 Food supplements contain-
ing ephedra alkaloids have been linked to adverse
cardiovascular and central nervous events.
4
Additionally, a case of ischemic colitis associated
with the use of an herbal product was reported
in a young woman.
5 In this paper, we examine the
strong association between the use of ma huang
and the development of ischemic colitis.
CASE REPORT
A 40-year-old man was admitted to our emer-
gency department with abdominal pain and
bloody diarrhea. The patient had watery diarrhea
for 3 days, but 3 hours prior to presentation, it
became bloody. He had neither a history of
symptoms suggestive of an inflammatory bowel
disease nor a recent history of antibiotic use. In
addition, he had neither a history of recent travel
nor a diet change. His medical history was unre-
markable for risk factors of bowel ischemia,
except for hypertension that was well controlled
with angiotensin receptor blockers. He smoked 1
pack of cigarette per day for 10 years, and there
was no family history of cerebrovascular or cardi-
vascular disease. Notably, he had been taking an
herbal food supplement, Ephedra sinica or ma
huang (total 1,000 mg; 3 times/day) throughout
the previous month for weight loss.
His blood pressure was 110/70 mmHg, pulse
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rate 73/min, respiratory rate 20/min, and body
temperature 36.5 . His body mass index was 25.7
kg/m
2. The patient appeared acutely ill but
otherwise was a healthy, well-nourished man. His
abdomen was soft and obese with mild tenderness
in the periumbilical area, and his bowel sounds
were normoactive. Laboratory data on admission
showed hemoglobin 15.6 g/dL, hematocrit 44.4%,
white blood cell count 7,500/mm
3, and platelet
214,000/mm
3. His serum sodium level was 138
mmol/L, potassium 4.1 mmol/L, chloride 103
mmol/L, fasting glucose 98 mg/dL, serum al-
bumin 3.9 g/dL, total cholesterol 145 mg/dL,
triglyceride 75 mg/dL, LDL cholesterol 81 mg/dL,
blood urea nitrogen 10 mg/dL, and creatinine 1.2
mg/dL. The patient's coagulation profiles were
normal. The stool white blood cell test was nega-
tive, while the stool occult blood test was positive.
Stool specimens were negative for enteric patho-
gens.
Abdominal and pelvic CT scans showed a
patent superior mesenteric artery and circum-
ferential wall thickening of the ascending, trans-
verse, and descending colon sparing the rectosig-
moid junction (Fig. 1). Colonoscopy performed on
admission showed findings compatible with
segmental colitis extending from the ascending to
the descending colon. The involved areas were
edematous and hyperemic, with areas of frank
hemorrhage (Fig. 2A). Three days after intra-
venous hydration and nutritional support, the
bloody diarrhea resolved. At an 8-day follow-up,
colonoscopy showed markedly improved mucosa
without any complications (Fig. 2B). The colono-
scopic biopsy specimen of the affected area
showed focal mucosal erosion and chronic inflam-
matory cell infiltration consistent with ischemic
colitis (Fig. 3).
The patient completely recovered without
complications and with only conservative mana-
gement. On discharge, he was advised to discon-
tinue the use of herbal medications and to avoid
any ephedrine- or pseudoephedrine-containing
cold remedies.
Fig. 2. (A) Colonoscopy on admission
show hemorrhagic friable mucosal
patches with mucosal edema from the
ascending to the descending colon. (B)
Colonoscopy at an 8-day follow-up
show marked mucosal improvement.
Fig. 1. Abdominal and pelvic CT
scans show a patent superior mesen-
teric artery (A) and edematous cir-
cumferential wall thickening of the
ascending, transverse, and descending
colon (B). A B
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DISCUSSION
Herbal weight loss supplements are popular
and may even be effective. Ma huang is a source
of ephedrine, a long-acting sympathomimetic that
acts primarily through the release of stored cate-
cholamine via - and -adrenoreceptors. α β
5 Ephedra
and ephedrine are sometimes used to achieve
weight loss or to enhance athletic performance,
but the efficacy and safety of these compounds
are uncertain.
6 Moreover, during the past decade,
a considerable number of reports regarding the
adverse effects of ephedra have led to an in-
creased awareness of the danger of these sympa-
thomimetics. For example, herbal ephedra and
ephedrine-containing food supplements have been
reported to increase the risks of adverse psychi-
atric, autonomic, and gastrointestinal events.
6
Furthermore, ephedrine and related alkaloids
have been associated with adverse cardiovascular
events, including acute myocardial infarction,
severe hypertension, myocarditis, and lethal
cardiac arrhythmia.
7-9 Ephedrine can also predis-
pose patients to both hemorrhagic and ischemic
stroke.
10
Ephedrine and ephedra are found to promote
short-term weight loss in clinical trials, but no
data are available regarding long-term weight
loss.
6 A recent study found that products contain-
ing ephedra accounted for 64% of all adverse
reactions to herbal supplements reported to the
US poison control centers in 2001, even though
they accounted for only 1% of the herbal supple-
ment market.
11 Although a number of clinical
trials have reported adverse events associated
with Ephedria sinica,
12-14 information regarding
the supplement is still incomplete. Ma huang is
considered to be potentially safe by the Food and
Drug Administration (FDA) when used orally for
a maximum of 7 days and in maximum doses of
24 mg/day of ephedrine equivalent.
15 However, in
light of recently reported adverse events, the FDA
has proposed limits on the dose and duration of
these supplements.
4 In this case, the patient was
taking ma huang in a dose about 6 times higher
than is recommended by the FDA. It is not sur-
prising, therefore, that ischemic colitis developed
in this patient. Infectious etiologies were also
ruled out with stool analysis.
Injury to the colon, especially ischemic colitis, in
patients using ma huang is presumably related to
reduced splanchnic blood flow due to vasocon-
strictions such as those seen in myocardial infarc-
tion
8 and ischemic stroke.
10 Potentially at-risk
areas include sites in the splenic flexure, de-
scending colon, and occasionally the rectosigmoid
junction. The areas between the superior and
inferior mesenteric arteries and between the lower
sigmoid and superior rectal arteries are known as
'watershed' areas.
5
Recently, a few cases of ischemic colitis have
been reported to be linked with decongestant
use.
16-17 In each of these cases, the vasoconstrictive
properties of pseudoephedrine were believed to
be the possible cause of ischemic colitis. More-
over, ischemic colitis after a dietary supplemen-
tation with phenteramine, an amphetamine-
derived sympathomimetic, has been reported.
18
Although our patient did not take decongestant
medications, his herbal diet supplements con-
tained ephedrine products, which were similar to
pseudoephedrine and caffeine products.
12-14
It is important to keep in mind that many
healthy people take a variety of herbal medica-
tions, believing that these medications are com-
pletely harmless. However, herbal products have
many active ingredients with pharmacologic
properties that may have undesirable effects. This
paper suggests that use of ma huang, a known
sympathomimetic and vasoconstrictor, carries a
risk for ischemic colitis in healthy people.
Fig. 3. Colonoscopic biopsy specimen from the transverse
colon show focal mucosal erosion and chronic inflam-
matory cell infiltration (H&E stain, × 200).Ischemic Colitis Associated with Ma Huang
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